C

Creyon Bio

43 employees

Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Life Science

Date founded

2019

Funding rounds raised

Total raised

$40M

from 3 investors over 3 rounds

C

Creyon Bio raised $40M on March 8, 2022

Investors: Casdin Capital, LLC, Lux Capital and DCVC Bio

FAQ